A Yale University study has found ibalizumab reduced viral replication and increased the count of immune cells in HIV patients, raising hopes for a new form of treatment for the disease.
French biotech Abivax might be on the verge of HIV cure and prevention discovery, after achieving a significant reduction of viral load patients during the first 28 days of treatment.
Around 10,000 people in England will get access to preventive HIV drugs in a landmark government-funded trial aimed at lowering infection rates among high-risk individuals.
Gilead’s new hepatitis C triple therapy Vosevi has been approved in the US, and will largely meet the needs of patients with difficult to treat forms of the disease.
Problems at a contract manufacturing organisation have scuppered Eli Lilly’s hopes of a timely FDA approval for lebrikizumab, its IL-13 inhibitor for the treatment of atop
Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho